Watson Pharmaceuticals has filed a law suit against the US FDA, challenging the Agency’s decision regarding Watson’s entitlement to shared exclusivity for its generic version of Takeda ...

Morgan Stanley Raises Price Target On Watson Pharmaceuticals To $78 Morgan Stanley Raises PT On Watson Pharmaceuticals To $78 Morgan Stanley Raises Price Target On Watson Pharmaceuticals To $78 ...

Watson Laboratories, a subsidiary of Watson Pharmaceuticals, has received approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Sildenafil Tablets, 20mg. Sildenafil is the ...

David O. Watson, the General Counsel of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), recently sold a portion of his holdings ...

Search for a state or federal candidate to see the donors and industries that support them. Ballot measures allow voters to vote directly on a law or policy change. Explore the ballot measures ...

David O. Watson, General Counsel of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), recently sold shares of the company amounting to $101,103. The transaction, which occurred on January 22 ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...